Klaus Okkenhaug
@klausokken.bsky.social
Professor of Immunology, Department of Pathology, University of Cambridge.
Research interests: PI3K, immunity, infection, cancer, immunotherapy.
Research interests: PI3K, immunity, infection, cancer, immunotherapy.
Great to welcome former PhD student, now Assistant Professor @krishaurum.bsky.social of the DTU back to the Department of Pathology. Excellent presentation on TIL TCRs, peptide-MHC complexes and his recent paper on AI-designed pMHC binders (artificial TCRs).
October 2, 2025 at 4:18 PM
Great to welcome former PhD student, now Assistant Professor @krishaurum.bsky.social of the DTU back to the Department of Pathology. Excellent presentation on TIL TCRs, peptide-MHC complexes and his recent paper on AI-designed pMHC binders (artificial TCRs).
Our latest paper reveals an intriguing and essential role for the class III #PI3K VPS34 in Treg homeostasis and function. Selective deletion of VPS34 in Treg led to a scurfy-like phenotype, suggesting an essential role for VPS34 in Treg-suppression.
doi.org/10.3389/fimm...
#immunosky
doi.org/10.3389/fimm...
#immunosky
November 27, 2024 at 10:38 AM
Our latest paper reveals an intriguing and essential role for the class III #PI3K VPS34 in Treg homeostasis and function. Selective deletion of VPS34 in Treg led to a scurfy-like phenotype, suggesting an essential role for VPS34 in Treg-suppression.
doi.org/10.3389/fimm...
#immunosky
doi.org/10.3389/fimm...
#immunosky
Congratulations to Julius Baeck who successfully passed his PhD viva last week! Many thanks to Claudia Mauri and Daniel Hodson who examined his thesis and engaged in a stimulating discussion!
October 29, 2024 at 11:39 AM
Congratulations to Julius Baeck who successfully passed his PhD viva last week! Many thanks to Claudia Mauri and Daniel Hodson who examined his thesis and engaged in a stimulating discussion!